Auxilium Pharmaceuticals (AUXL) 36.47 $AUXL
Auxilium Pharmaceuticals Up 80.6% Since SmarTrend Uptrend Call (AUXL)
Comtex SmarTrend(R) - Fri Feb 13, 9:09AM CST
SmarTrend identified an Uptrend for Auxilium Pharmaceuticals (NASDAQ:AUXL) on September 4th, 2014 at $20.20. In approximately 5 months, Auxilium Pharmaceuticals has returned 80.59% as of today's recent price of $36.47.
AUXL: 36.47 (-0.06)
Auxilium Pharmaceuticals Has Returned 80.6% Since SmarTrend Recommendation (AUXL)
Comtex SmarTrend(R) - Thu Feb 05, 4:36PM CST
SmarTrend identified an Uptrend for Auxilium Pharmaceuticals (NASDAQ:AUXL) on September 4th, 2014 at $20.20. In approximately 5 months, Auxilium Pharmaceuticals has returned 80.59% as of today's recent price of $36.47.
AUXL: 36.47 (-0.06)
Auxilium Announces Fundamental Change and Make-Whole Fundamental Change Relating to Outstanding Convertible Senior Notes
PR Newswire Europe - Tue Feb 03, 7:01AM CST
Auxilium Pharmaceuticals, Inc. ("Auxilium"
today announced that it has delivered a notice to holders of its 1.50% convertible senior notes due 2018 (the "Notes" , pursuant to the indenture governing the Notes (as supplemented, the "Indenture" , notifying holders that, as a result of each of the merger (the "Merger" contemplated by the Amended and Restated Agreement and Plan of Merger, dated as of November 17, 2014, among Auxilium, Endo International plc ("Endo" , Endo U.S. Inc. and Avalon Merger Sub Inc., and the termination of trading of Auxilium common stock on NASDAQ, a "Fundamental Change" and a "Make-Whole Fundamental Change," each as defined in the Indenture, has occurred effective as of January 29, 2015.
AUXL: 36.47 (-0.06)
BioSpecifics Technologies Corp. Announces Approval of XIAPEX® in the EU for the Treatment of Peyronie's Disease
PR Newswire - Mon Feb 02, 7:30AM CST
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced that Swedish Orphan Biovitrum AB (Sobi) has received approval from the EU Commission to market XIAPEX for the treatment of adult men with Peyronie's disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy. XIAFLEX has been approved in the U.S. for Peyronie's disease since December 2013 and is marketed by BioSpecifics' strategic partner Auxilium Pharmaceuticals, Inc. (Auxilium), now a wholly-owned subsidiary of Endo International plc.
BSTC: 38.14 (-0.85), AUXL: 36.47 (-0.06)
Winners Circle 2014 Top Hedge Fund Managers: Healthcare Funds, Nine Of Top Ten Spots
GuruFundPicks - at Seeking Alpha - Thu Jan 29, 7:04PM CST
BLUE: 90.70 (+0.93), ABMD: 60.39 (+0.46), AUXL: 36.47 (-0.06), ASPX: 65.76 (+2.76), AAVL: 36.29 (+0.01)
Endo Completes Acquisition Of Auxilium Pharmaceuticals
PR Newswire Europe - Thu Jan 29, 3:30PM CST
Endo International plc today announced it has completed the acquisition of Auxilium Pharmaceuticals, Inc. in a transaction valued at $2.6 billion when announced on October 9, 2014. The closing of the transaction follows the approval of the acquisition by Auxilium's shareholders on January 27, 2015, and the receipt of all required regulatory approvals.
ENDP: 84.01 (+1.12), ENL.TO: 103.00 (unch), AUXL: 36.47 (-0.06)
Shares of AUXL Up 80.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 29, 10:56AM CST
SmarTrend identified an Uptrend for Auxilium Pharmaceuticals (NASDAQ:AUXL) on September 4th, 2014 at $20.20. In approximately 5 months, Auxilium Pharmaceuticals has returned 80.69% as of today's recent price of $36.49.
AUXL: 36.47 (-0.06)
Auxilium Announces Results from Special Meeting of Stockholders
PR Newswire - Tue Jan 27, 8:32AM CST
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, announced that it held a special meeting of its stockholders today at 8:30 a.m. ET to approve matters relating to the previously announced proposed merger with Endo International plc. The proposal to adopt the amended and restated agreement and plan of merger was passed by stockholders with approximately 84 percent of outstanding shares voting in favor.
AUXL: 36.47 (-0.06)
Endo Prices $1.2B Senior Notes Offering for Auxilium Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 22, 4:10PM CST
Endo International has priced $1.2 billion aggregate principal amount of 6.00% senior notes due Feb 2025 at par with a face value of $1,000 on Jan 20.
ENDP: 84.01 (+1.12), AUXL: 36.47 (-0.06), ALXN: 182.29 (+6.02), AMAG: 41.49 (+0.23)
Auxilium Pharmaceuticals Has Returned 79.7% Since SmarTrend Recommendation (AUXL)
Comtex SmarTrend(R) - Thu Jan 22, 9:35AM CST
SmarTrend identified an Uptrend for Auxilium Pharmaceuticals (NASDAQ:AUXL) on September 4th, 2014 at $20.20. In approximately 5 months, Auxilium Pharmaceuticals has returned 79.70% as of today's recent price of $36.29.
AUXL: 36.47 (-0.06)
Today In SA PRO: Wednesday, January 21
SA PRO Top Ideas - at Seeking Alpha - Thu Jan 22, 4:00AM CST
Outstanding Performance Award Winner #1: Short idea on PBR (Petrobras) by Richard Berger, published September 29, 2014. Return to date: +57% (See author update » ) Outstanding Performance Award Winner #2: Long idea on SBGL (Sibanye...
COUP: 11.06 (-0.07), AUXL: 36.47 (-0.06)
Endo International plc Announces Pricing of Private Offering Of Senior Notes
PR Newswire Europe - Wed Jan 21, 7:02AM CST
Endo International plc ("Endo" today announced that on January 20, 2015, Endo Limited, Endo Finance LLC and Endo Finco Inc., its wholly-owned subsidiaries, priced $1.2 billion aggregate principal amount of 6.00% senior notes due February 2025 at an issue price of $1,000 per $1,000 principal amount in connection with their previously announced private offering. The notes will be unsecured, unsubordinated obligations of Endo Limited, Endo Finance LLC and Endo Finco Inc. and will be guaranteed by certain of Endo Limited's direct and indirect subsidiaries.
ENDP: 84.01 (+1.12), ENL.TO: 103.00 (unch), AUXL: 36.47 (-0.06)
Wall Street Breakfast: Gold Rises Ahead Of ECB Meeting
Wall Street Breakfast - at Seeking Alpha - Wed Jan 21, 5:31AM CST
QEPM: 16.66 (+0.36), AMZN: 381.83 (+4.66), GE: 25.15 (+0.26), SNE: 27.30 (+0.19), TM: 132.49 (+0.67), MHFI: 102.19 (unch), GOOG: 549.01 (+6.08), COUP: 11.06 (-0.07), SPY: 209.78 (+0.86), QQQ: 106.91 (+0.91), IBM: 160.40 (+1.88), BHP: 51.19 (+2.38), QCOM: 70.88 (+0.49), AUXL: 36.47 (-0.06), AAL: 48.39 (+0.51), GOOGL: 551.16 (+5.15), BP: 41.93 (+0.59), TWC: 149.74 (+2.21)
Endo International plc Announces Proposed Private Offering Of Senior Notes
PR Newswire Europe - Tue Jan 20, 7:30AM CST
Endo International plc ("Endo" today announced that Endo Limited, Endo Finance LLC and Endo Finco Inc., its wholly-owned subsidiaries, intend to offer senior notes, subject to market and customary conditions. The notes will be unsecured, unsubordinated obligations of Endo Limited, Endo Finance LLC and Endo Finco Inc. and will be guaranteed by certain of Endo Limited's direct and indirect subsidiaries.
ENDP: 84.01 (+1.12), ENL.TO: 103.00 (unch), AUXL: 36.47 (-0.06)
Auxilium Pharmaceuticals Up 80.6% Since SmarTrend Uptrend Call (AUXL)
Comtex SmarTrend(R) - Fri Feb 13, 9:09AM CST
SmarTrend identified an Uptrend for Auxilium Pharmaceuticals (NASDAQ:AUXL) on September 4th, 2014 at $20.20. In approximately 5 months, Auxilium Pharmaceuticals has returned 80.59% as of today's recent price of $36.47.
AUXL: 36.47 (-0.06)
Auxilium Pharmaceuticals Has Returned 80.6% Since SmarTrend Recommendation (AUXL)
Comtex SmarTrend(R) - Thu Feb 05, 4:36PM CST
SmarTrend identified an Uptrend for Auxilium Pharmaceuticals (NASDAQ:AUXL) on September 4th, 2014 at $20.20. In approximately 5 months, Auxilium Pharmaceuticals has returned 80.59% as of today's recent price of $36.47.
AUXL: 36.47 (-0.06)
Auxilium Announces Fundamental Change and Make-Whole Fundamental Change Relating to Outstanding Convertible Senior Notes
PR Newswire Europe - Tue Feb 03, 7:01AM CST
Auxilium Pharmaceuticals, Inc. ("Auxilium"
today announced that it has delivered a notice to holders of its 1.50% convertible senior notes due 2018 (the "Notes" , pursuant to the indenture governing the Notes (as supplemented, the "Indenture" , notifying holders that, as a result of each of the merger (the "Merger" contemplated by the Amended and Restated Agreement and Plan of Merger, dated as of November 17, 2014, among Auxilium, Endo International plc ("Endo" , Endo U.S. Inc. and Avalon Merger Sub Inc., and the termination of trading of Auxilium common stock on NASDAQ, a "Fundamental Change" and a "Make-Whole Fundamental Change," each as defined in the Indenture, has occurred effective as of January 29, 2015. AUXL: 36.47 (-0.06)
BioSpecifics Technologies Corp. Announces Approval of XIAPEX® in the EU for the Treatment of Peyronie's Disease
PR Newswire - Mon Feb 02, 7:30AM CST
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced that Swedish Orphan Biovitrum AB (Sobi) has received approval from the EU Commission to market XIAPEX for the treatment of adult men with Peyronie's disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy. XIAFLEX has been approved in the U.S. for Peyronie's disease since December 2013 and is marketed by BioSpecifics' strategic partner Auxilium Pharmaceuticals, Inc. (Auxilium), now a wholly-owned subsidiary of Endo International plc.
BSTC: 38.14 (-0.85), AUXL: 36.47 (-0.06)
Winners Circle 2014 Top Hedge Fund Managers: Healthcare Funds, Nine Of Top Ten Spots
GuruFundPicks - at Seeking Alpha - Thu Jan 29, 7:04PM CST
BLUE: 90.70 (+0.93), ABMD: 60.39 (+0.46), AUXL: 36.47 (-0.06), ASPX: 65.76 (+2.76), AAVL: 36.29 (+0.01)
Endo Completes Acquisition Of Auxilium Pharmaceuticals
PR Newswire Europe - Thu Jan 29, 3:30PM CST
Endo International plc today announced it has completed the acquisition of Auxilium Pharmaceuticals, Inc. in a transaction valued at $2.6 billion when announced on October 9, 2014. The closing of the transaction follows the approval of the acquisition by Auxilium's shareholders on January 27, 2015, and the receipt of all required regulatory approvals.
ENDP: 84.01 (+1.12), ENL.TO: 103.00 (unch), AUXL: 36.47 (-0.06)
Shares of AUXL Up 80.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 29, 10:56AM CST
SmarTrend identified an Uptrend for Auxilium Pharmaceuticals (NASDAQ:AUXL) on September 4th, 2014 at $20.20. In approximately 5 months, Auxilium Pharmaceuticals has returned 80.69% as of today's recent price of $36.49.
AUXL: 36.47 (-0.06)
Auxilium Announces Results from Special Meeting of Stockholders
PR Newswire - Tue Jan 27, 8:32AM CST
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, announced that it held a special meeting of its stockholders today at 8:30 a.m. ET to approve matters relating to the previously announced proposed merger with Endo International plc. The proposal to adopt the amended and restated agreement and plan of merger was passed by stockholders with approximately 84 percent of outstanding shares voting in favor.
AUXL: 36.47 (-0.06)
Endo Prices $1.2B Senior Notes Offering for Auxilium Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 22, 4:10PM CST
Endo International has priced $1.2 billion aggregate principal amount of 6.00% senior notes due Feb 2025 at par with a face value of $1,000 on Jan 20.
ENDP: 84.01 (+1.12), AUXL: 36.47 (-0.06), ALXN: 182.29 (+6.02), AMAG: 41.49 (+0.23)
Auxilium Pharmaceuticals Has Returned 79.7% Since SmarTrend Recommendation (AUXL)
Comtex SmarTrend(R) - Thu Jan 22, 9:35AM CST
SmarTrend identified an Uptrend for Auxilium Pharmaceuticals (NASDAQ:AUXL) on September 4th, 2014 at $20.20. In approximately 5 months, Auxilium Pharmaceuticals has returned 79.70% as of today's recent price of $36.29.
AUXL: 36.47 (-0.06)
Today In SA PRO: Wednesday, January 21
SA PRO Top Ideas - at Seeking Alpha - Thu Jan 22, 4:00AM CST
Outstanding Performance Award Winner #1: Short idea on PBR (Petrobras) by Richard Berger, published September 29, 2014. Return to date: +57% (See author update » ) Outstanding Performance Award Winner #2: Long idea on SBGL (Sibanye...
COUP: 11.06 (-0.07), AUXL: 36.47 (-0.06)
Endo International plc Announces Pricing of Private Offering Of Senior Notes
PR Newswire Europe - Wed Jan 21, 7:02AM CST
Endo International plc ("Endo"
today announced that on January 20, 2015, Endo Limited, Endo Finance LLC and Endo Finco Inc., its wholly-owned subsidiaries, priced $1.2 billion aggregate principal amount of 6.00% senior notes due February 2025 at an issue price of $1,000 per $1,000 principal amount in connection with their previously announced private offering. The notes will be unsecured, unsubordinated obligations of Endo Limited, Endo Finance LLC and Endo Finco Inc. and will be guaranteed by certain of Endo Limited's direct and indirect subsidiaries. ENDP: 84.01 (+1.12), ENL.TO: 103.00 (unch), AUXL: 36.47 (-0.06)
Wall Street Breakfast: Gold Rises Ahead Of ECB Meeting
Wall Street Breakfast - at Seeking Alpha - Wed Jan 21, 5:31AM CST
QEPM: 16.66 (+0.36), AMZN: 381.83 (+4.66), GE: 25.15 (+0.26), SNE: 27.30 (+0.19), TM: 132.49 (+0.67), MHFI: 102.19 (unch), GOOG: 549.01 (+6.08), COUP: 11.06 (-0.07), SPY: 209.78 (+0.86), QQQ: 106.91 (+0.91), IBM: 160.40 (+1.88), BHP: 51.19 (+2.38), QCOM: 70.88 (+0.49), AUXL: 36.47 (-0.06), AAL: 48.39 (+0.51), GOOGL: 551.16 (+5.15), BP: 41.93 (+0.59), TWC: 149.74 (+2.21)
Endo International plc Announces Proposed Private Offering Of Senior Notes
PR Newswire Europe - Tue Jan 20, 7:30AM CST
Endo International plc ("Endo"
today announced that Endo Limited, Endo Finance LLC and Endo Finco Inc., its wholly-owned subsidiaries, intend to offer senior notes, subject to market and customary conditions. The notes will be unsecured, unsubordinated obligations of Endo Limited, Endo Finance LLC and Endo Finco Inc. and will be guaranteed by certain of Endo Limited's direct and indirect subsidiaries. ENDP: 84.01 (+1.12), ENL.TO: 103.00 (unch), AUXL: 36.47 (-0.06)
